Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) — Cash Flow Quality Index
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) has a Cash Flow Quality Index of 4.38x as of December 2025. Operating cash flow of CN¥837.18 Million exceeds net income of CN¥191.35 Million, indicating high earnings quality where cash backs reported profits. Also explore Anhui Huaren Health Pharmaceutical Co. L asset portfolio for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A Cash Flow Quality Index (2021–2025)
Historical Cash Flow Quality Index for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 301408 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (2021–2025)
Year-by-year earnings quality comparison for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A. For live market cap and the full company financial profile, see market value of Anhui Huaren Health Pharmaceutical Co. L.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 4.38x | CN¥837.18 Million | CN¥191.35 Million | ▲ +5.4% |
| 2024 | 4.15x | CN¥571.76 Million | CN¥137.70 Million | ▲ +262.4% |
| 2023 | 1.15x | CN¥131.37 Million | CN¥114.67 Million | ▲ +6.0% |
| 2022 | 1.08x | CN¥173.84 Million | CN¥160.78 Million | ▼ -46.5% |
| 2021 | 2.02x | CN¥140.82 Million | CN¥69.73 Million | — |